RESOURCE LISTINGS – Following 2018 Forum

MDMA RESEARCH STUDY – REFERRAL/SELF REFERRAL – WAITLIST
At the 2018 Forum, Hayden Rubensohn, MD,  mentioned that the MDMA Phase III research study in Vancouver is inviting clinicians to refer patients or for people to self refer. Just email maps.trial.bc@gmail.com if you are interested. People who email can expect a generic reply, and that email address will be added to the waiting list. Email addresses will be picked by a random number generator. The picked people will be emailed and a screening process will be undertaken for the study.
______________________________________
THERAPEUTIC PSILOCYBIN FOR CANADIANS
Bruce Tobin, PhD, is spreading the word about the mission of Therapeutic Psilocybin for Canadians — currently comprising of a group of seven health professionals who seek to make psilocybin, a psychedelic medicine, legally available to Canadians in need of compassionate treatment for severe psychological distress. Bruce notes: “We are dedicated to providing safe and legal psilocybin-assisted psychotherapy to Canadian cancer patients suffering from end-of-life psychological distress. Learn about our application to Health Canada, and our plan to challenge existing federal law to permit compassionate treatment NOW.”
***
____________________________
PSI 2020 CAMPAIGN – IN OREGON
Tom and Sheri Eckert shared how they are campaigning to mainstream “psilocybin services” in the U.S. state of Oregon. For more information:
_______________________
AYAHUASCA – RESOURCES
Here are useful links from ICEERS and Women’s Visionary Council, addressing Ayahuasca and promoting practices of safety:
__________________________________
MODERN SPIRIT EPIGENETICS PROJECT
Joe Tafur, MD, shared about the Modern Spirit Epigenetics Project at the 2018 Forum. He notes that Trauma Healing and Psychedelic Psychotherapy have the power to shift our Biology — To learn more please visit modernspirit.org
_________________
OTHER RESOURCES
Phil Wolfson, MD – Ketamine Resource Foundation
***
Veronika Gold, LMFT, who moderated the panels on Ketamine-assisted Psychotherapy and MDMA Clinical Trials for PTSD at the 2018 Forum, offered a resource link here – including useful articles, videos, and safety considerations.
_________________